Kalorama Coronavirus News, Updates, IVD Market Impact

The novel 2019 coronavirus originating in the Hubei province in China and spreading to several nations worldwide has put the tools of IVD vendors to work, particularly reverse transcription polymerase chain reaction (RT-PCR) systems and sequencers.  Kalorama has created this page to update on the latest IVD-related news from Kalorama and our sister publication LabPulse.com (www.labpulse.com)

The first known cases emerged in December 2019 and were traced to an animal market in Wuhan, China, from patients who are believed to have come in contact with live animals that were infected. Wuhan is a large hub city with a population of 11 million, located 500 miles from Shanghai. At the time of writing, 81 people had died from the virus and 2,700 were infected, with reports changing rapidly. The spread of the disease to other nations including the U.S. is a top story in the news media and, of course, a concern to laboratorians.  Coronavirus has been made a public health emergency by the U.S. Secretary of Health and Human Services (HHS) on January 31 and the World Health Organization (WHO) on January 30.


Virus Deaths Outside China Rise


CT vs. DNA testing:  one study shows how imaging supplements lab tests for diagnosing coronavirus disease


CDC wrestles with coronavirus test problems in states


New Name for coronavirus disease “COVID-19”


CMS Warns Lab Regulations Still in Place After FDA’s EUA of Coronavirus Test


HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment


 Ask patients One Question, Says Anthony Fauci at NIH


Germany’s Genekam rolls out Wuhan coronavirus test


FDA Shares CDC Test Under EUA Authority; Public Labs with High Complexity Certification Can Use Test


RT-PCR Delivering Fast Results in Crisis


Enrichment NGS emerges as surveillance tool for coronavirus


Laboratories, IVD vendors get to work on novel coronavirus